Developing and delivering our strategy
In developing this strategy, we have created a dynamic and innovative approach for delivery of the leading treatments and care for every patient. Developed in conjunction with our stakeholders, both internal and external, it provides the blueprint to drive our services forward to benefit patients.
We took an inclusive and integrated approach to developing this strategy.
The steps taken included:
- Trust Board and Executive Team development sessions to agree high-level external drivers and challenges
- Communication and involvement of staff, patients, carers and support groups
- Communication and involvement of acute, ICS and primary care colleagues
We consulted and communicated with:
Internal stakeholders
- Multidisciplinary clinical staff
- Medical consultants
- Departmental meetings
- Clinical staff
- Non-clinical meetings/departments
- Governors
- Trust members
- Executive and Non-Executive Directors
- The Walton Centre Charity
External stakeholders
- Neuro Therapy Centre
- The Brain Charity
- Parkinson’s UK
- Epilepsy Action
- MS Society
- MND Association
- Cheshire and Merseyside Neurological Alliance
- West Cheshire and North Wales Neurological Alliance
- Isle of Man Neurological Alliance
- North Wales Neuroscience Board
- Health Watch
- Integrated care partners
- General Practitioners
- TIDE
- NHS partners
- Universities
- Cheshire West Partnership
- Public Health
- Pain Relief Foundation
- Social services
- Public members
This is a bold but clear and ambitious strategy, developed by our staff, patients, families, carers and support groups.
A series of launch and engagement events will be held. The strategy will be a visible and dynamic framework for our organisation.
We will deliver the ambitions within the strategy using our existing transformational model, which is closely aligned with the operational teams within both our clinical and non-clinical divisions.
Annual priorities will be set which will form our strategic objectives and framework.
This strategy builds on our existing leadership of neurosciences, and our level of treatment and care, and provides a platform to further strengthen patient and family experience, collaboration and transformation.